[PDF][PDF] Thyroid diseases in elderly

A Faggiano, M Del Prete, F Marciello… - Minerva …, 2011 - researchgate.net
Thyroid diseases are the commonest endocrine disorders in the general population. In most
of the cases, they are consistent with benign conditions which may be asymptomatic or affect …

[HTML][HTML] Circular RNA circKIF4A facilitates the malignant progression and suppresses ferroptosis by sponging miR-1231 and upregulating GPX4 in papillary thyroid …

W Chen, J Fu, Y Chen, Y Li, L Ning, D Huang… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
Circular RNAs (circRNAs) are one type of non-coding RNA. They act as important role in
regulating various biological processes in the malignant progression. But we don't clearly …

ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1–Nrf2/HO-1 axis

W Li, G Huang, J Wei, H Cao, G Jiang - Molecular and Cellular …, 2023 - Springer
As a critical catalytic subunit of N6-methyladenosine (m6A) modification in messenger RNA,
ALKBH5 has been reported to affect the progression of numerous tumors. However, the …

[HTML][HTML] Long non-coding ROR promotes the progression of papillary thyroid carcinoma through regulation of the TESC/ALDH1A1/TUBB3/PTEN axis

Y Fan, X Fan, H Yan, Z Liu, X Wang, Q Yuan… - Cell Death & …, 2022 - nature.com
Papillary thyroidal carcinoma (PTC) is a common endocrine cancer that plagues people
across the world. The potential roles of long non-coding RNAs (lncRNAs) in PTC have …

[HTML][HTML] Discovery and identification of potential biomarkers of papillary thyroid carcinoma

Y Fan, L Shi, Q Liu, R Dong, Q Zhang, S Yang, Y Fan… - Molecular Cancer, 2009 - Springer
Background Thyroid carcinoma is the most common endocrine malignancy and a common
cancer among the malignancies of head and neck. Noninvasive and convenient biomarkers …

[HTML][HTML] Emerging role of ferroptosis-related circular RNA in tumor metastasis

Y Meng, J Cao, Y Li, S Duan, Z Zhou, J Li… - Frontiers in …, 2023 - frontiersin.org
Tumor metastasis is an important factor that contributes to the poor prognosis of patients with
tumors. Therefore, to solve this problem, research on the mechanism of metastasis is …

[HTML][HTML] Plasma-derived miRNA-222 as a candidate marker for papillary thyroid cancer

A Kondrotienė, A Daukša, D Pamedytytė… - International journal of …, 2020 - mdpi.com
We analyzed five miRNA molecules (miR-221; miR-222; miR-146b; miR-21; miR-181b) in
the plasma of patients with papillary thyroid cancer (PTC), nodular goiter (NG) and healthy …

[HTML][HTML] Upregulated circRAD18 promotes tumor progression by reprogramming glucose metabolism in papillary thyroid cancer

W Chen, T Zhang, Y Bai, H Deng, F Yang, R Zhu… - Gland …, 2021 - ncbi.nlm.nih.gov
Background By regulating complex functional processes, circRNAs are crucial in the
development of different cancers. Nevertheless, most circRNAs in papillary thyroid cancer …

The role of BRAF (V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma

MR Pelizzo, C Dobrinja, EC Ide, M Zane, O Lora… - Biomedicine & …, 2014 - Elsevier
Abstract Background BRAF (V600E) mutation, which represents the most frequent genetic
mutation in papillary thyroid carcinoma (PTC), is widely considered to have an adverse …

Should multifocality be an indication for prophylactic central neck dissection in papillary thyroid cancer?

K Ozdemir, AT Harmantepe, E Gonullu, B Kocer… - Updates in Surgery, 2023 - Springer
Although multifocality is common in patients with papillary thyroid cancer, its effects on
lymphatic metastasis and the necessity of central dissection in the presence of multifocality …